Comparison of Borate Bioactive Glass and Calcium Sulfate As Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus Aureus-Induced Osteomyelitis in a Rabbit Model
Abstract
There is growing interest in biomaterials that can cure bone infection and also regenerate bone. In this study, two groups of implants composed of 10% (wt/wt) teicoplanin (TEC)-loaded borate bioactive glass (designated TBG) or calcium sulfate (TCS) were created and evaluated for their ability to release TEC in vitro and to cure methicillin-resistant Staphylococcus aureus (MRSA)- induced osteomyelitis in a rabbit model. When immersed in phosphate-buffered saline (PBS), both groups of implants provided a sustained release of TEC at a therapeutic level for up to 3 to 4 weeks while they were gradually degraded and converted to hydroxyapatite. The TBG implants showed a longer duration of TEC release and better retention of strength as a function of immersion time in PBS. Infected rabbit tibiae were treated by debridement, followed by implantation of TBG or TCS pellets or intravenous injection with TEC, or were left untreated. Evaluation at 6 weeks postimplantation showed that the animals implanted with TBG or TCS pellets had significantly lower radiological and histological scores, lower rates of MRSA-positive cultures, and lower bacterial loads than those preoperatively and those of animals treated intravenously. The level of bone regeneration was also higher in the defects treated with the TBG pellets. The results showed that local TEC delivery was more effective than intravenous administration for the treatment of MRSA-induced osteomyelitis. Borate glass has the advantages of better mechanical strength, more desirable kinetics of release of TEC, and a higher osteogenic capacity and thus could be an effective alternative to calcium sulfate for local delivery of TEC.
Recommended Citation
W. Jia et al., "Comparison of Borate Bioactive Glass and Calcium Sulfate As Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus Aureus-Induced Osteomyelitis in a Rabbit Model," Antimicrobial Agents and Chemotherapy, vol. 59, no. 12, pp. 7571 - 7580, American Society for Microbiology, Dec 2015.
The definitive version is available at https://doi.org/10.1128/AAC.00196-15
Department(s)
Materials Science and Engineering
International Standard Serial Number (ISSN)
0066-4804
Document Type
Article - Journal
Document Version
Citation
File Type
text
Language(s)
English
Rights
© 2015 American Society for Microbiology, All rights reserved.
Publication Date
01 Dec 2015